Lucinda J. Van Anglen

Real-World Prescribing Patterns of Certolizumab in the Treatment of Crohn’s Disease

BACKGROUND: Certolizumab (CZP) is a pegylated anti-tumor necrosis factor (TNF) agent approved for the treatment of moderate-to-severe Crohn’s disease (CD). CZP therapy has proven effectiv...

Timothy Ritter ;

Chris Fourment ;

Samantha Kuten ;

Lucinda J. Van Anglen ;

12/12/2019

Biologic Therapy Sequencing in Ulcerative Colitis: A Real-World Observational Study of Second-Line Therapy After Vedolizumab

1 Anne Marion Burnett School of Medicine, Fort Worth, Texas, United States; 2 Healix Infusion Therapy, LLC, Sugar Land, Texas, United States; 3 GI Alliance, United States; 4 Takeda Pharma...

Casey Chapman ;

Lisa Young ;

Timothy Ritter ;

Lucinda J. Van Anglen ;

Christopher Fernandes ;

Precious A. Anyanwu ;

Harry Sarles ;

Chiahung Chou ;

Jeanne Jiang ;

Marie Sanchirico ;

Tao Fan ;

01/11/2024